相关实验视频
Updated: Jan 6, 2026

14:54
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
Published on: January 27, 2019
11.7K
[儿科败血症的临床特征和预后风险评估]
1Children's Medical Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China.
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
|November 25, 2025
概括
卡什加的儿科败血症通常与胃肠道感染有关. 儿童物流器官功能障碍-2 (PELOD-2) 的高分数和格拉斯哥昏迷量表 (GCS) 的低分数预测了败血症儿童的不良结果.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 临界护理医学 临界护理医学
背景情况:
- 儿科败血症是一个重大的公共卫生挑战,需要对其流行病学特征和预后因素有更深入的了解.
- 儿科败血症发病率和结果的区域差异需要量身定制的公共卫生战略.
研究的目的:
- 分析卡什加地区儿科败血症的流行病学特征.
- 确定与儿科败血症患者的预后相关的因素,以告知公共卫生政策.
主要方法:
- 一项回顾性观察性研究分析了2022年1月至2023年12月入住儿科重症监护室 (PICU) 的79名儿科败血症患者的临床数据.
- 患者根据住院时间和生存状况进行分类.
- 使用单变量和二进制逻辑回归分析来确定预后的独立风险因素.
主要成果:
- 最常见的感染来源是胃肠道 (34.2%),其次是呼吸道 (30.4%).
- 住院死亡率为19.0%.
- 高的儿科物流器官功能障碍-2 (PELOD-2) 评分 (OR: 1.38) 是预后不佳的独立风险因素,而高的格拉斯哥昏迷度量 (GCS) 评分 (OR: 0.81) 是保护性的. 结合PELOD-2和GCS模型显示出良好的预测能力 (AUC=0.82).
结论:
- 胃肠道感染是卡什加地区儿童败血症的主要来源.
- 升高的PELOD-2分数和降低的GCS是儿科败血症预后不佳的重要指标.
- 使用PELOD-2和GCS的综合预后模型可以帮助评估儿科败血症患者的结果.
相关概念视频
Pneumonia III: Complications and Assessment
752
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
752
Acute Kidney Injury III: Clinical Manifestations
754
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
754
Factors Affecting the Risk of Infection
13.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.2K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
219
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
219
Pharmacokinetics in Pediatric Patients: Drug Distribution
231
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165

